Implant Centre Martinko has been acquired by Adria Dental Group
Adria Dental Group (ADG) has acquired Implant Centre Martinko (ICM) from a private individual who was also its head surgeon. This investment represents a significant strategic move for ADG, marking its entry into the Italian market, strengthening its position in Croatia and opening new opportunities for growth. Both entities will see improvements in patient care quality through this collaboration, and ICM employees will benefit from enhanced working conditions.
ICM is a renowned Croatian dental implant center, with a clinic in Zagreb and two clinics in Milan and Trieste, Italy. It offers a range of services, including dental implantology, prosthetics and conservative and aesthetic dentistry. The company is a pioneer in positioning Croatia as a destination for high-quality dental services in the EU market and beyond.
Adria Dental Group is the largest dental group in the Adriatic region, operating 12 clinics across Croatia and Slovenia, over 150 cutting-edge dental offices and nine high-end laboratories. The group employs over 700 professionals and treats nearly 55,000 patients annually.
Provectus Capital Partners (PCP) is a private equity firm operating in Southeast Europe, with a primary focus on investments in healthcare companies across Croatia and neighboring countries such as Slovenia.
Oaklins’ team in Croatia was mandated as the sell-side advisor to the seller.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more